Clinical Trial Update: Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two NN5401 formulations with metformin against biphasic insulin aspart 30 plus metformin in adults with Type 2 diabetes. Results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin aspart 30, biphasic (insulin aspart 30)
• NN5401
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2015-12-01